Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Residual drug in patient samples may impair detection of neutralizing antibodies (NAb). To facilitate NAb detection in test samples with high drug concentrations, Intertek developed a novel approach based on PK data and NAb assay response modeling, improving drug tolerance without labor-consuming and potentially damaging sample pretreatment procedures.
Complete the form below to download the complimentary poster: Drug Tolerance Assessment and Improvement in Cell Based NAb Assays Using Response Data Modeling.